These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16287519)

  • 1. [Hepatic failure due to nevirapine treatment for HIV infection].
    Mens H; Katzenstein TL
    Ugeskr Laeger; 2005 Nov; 167(46):4359. PubMed ID: 16287519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-daily dosing of nevirapine in HAART.
    Clotet B
    J Antimicrob Chemother; 2008 Jan; 61(1):13-6. PubMed ID: 18006524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
    Saghayam S; Kumarasamy N; Cecelia AJ; Solomon S; Mayer K; Wanke C
    Clin Infect Dis; 2007 Jan; 44(2):295-300. PubMed ID: 17173234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for fulminant hepatitis related to nevirapine therapy.
    Buyse S; Vibert E; Sebagh M; Antonini T; Ichai P; Castaing D; Samuel D; Duclos-Vallée JC
    Liver Transpl; 2006 Dec; 12(12):1880-2. PubMed ID: 17133571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral adverse effects due to the use of Nevirapine.
    Moura MD; Senna MI; Madureira DF; Fonseca LM; Mesquita RA
    J Contemp Dent Pract; 2008 Jan; 9(1):84-90. PubMed ID: 18176653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do we still need lead-in dosing of nevirapine in HIV-infected patients who are receiving rifampicin-containing antituberculous therapy?
    Chang SY; Lin SW; Hung CC
    Clin Infect Dis; 2009 Nov; 49(9):1452-3; author reply 1453-4. PubMed ID: 19824849
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxic epidermal necrolysis induced by nevirapine therapy: description of two cases and review of the literature.
    Cattelan AM; Trevenzoli M; Sasset L; Sgarabotto D; Lanzafame M; Meneghetti F
    J Infect; 2001 Nov; 43(4):246-9. PubMed ID: 11869062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
    Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
    AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urgent liver transplantation for nevirapine-induced acute liver failure: report of a case and review of the literature.
    Lopez-Delgado JC; Mendiluce RM; Pinol TS; Fernández XP; Sanchez L; Vicente RG
    Ann Transplant; 2012; 17(1):122-7. PubMed ID: 22466918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reasons for discontinuation of nevirapine-containing HAART: results from an unselected population of a large clinical cohort.
    Maggiolo F; Arici C; Airoldi M; Ripamonti D; Quinzan G; Gregis G; Ravasio V; Bombana E; Suter F
    J Antimicrob Chemother; 2007 Mar; 59(3):569-72. PubMed ID: 17255141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes zoster infection in HIV-seropositive patients associated with highly active antiretroviral therapy.
    Aldeen T; Hay P; Davidson F; Lau R
    AIDS; 1998 Sep; 12(13):1719-20. PubMed ID: 9764795
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.
    Olawumi HO; Olatunji PO; Salami AK; Odeigah L; Iseniyi JO
    Niger J Clin Pract; 2008 Dec; 11(4):312-5. PubMed ID: 19320401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Most common prescribing error in postexposure prophylaxis of HIV/AIDS.
    Mahajan A; Sharma H; Bhagat A; Tandon VR; Sharma R; Sharma S
    J Assoc Physicians India; 2007 Mar; 55():246-7. PubMed ID: 17598343
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin.
    Manosuthi W; Sungkanuparph S; Thakkinstian A; Rattanasiri S; Chaovavanich A; Prasithsirikul W; Likanonsakul S; Ruxrungtham K
    Clin Infect Dis; 2006 Jul; 43(2):253-5. PubMed ID: 16779754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of highly active antiretroviral therapy modifications in patients with acute or early human immunodeficiency virus infection.
    Sabundayo BP; McArthur JH; Langan SJ; Gallant JE; Margolick JB
    Pharmacotherapy; 2006 May; 26(5):674-81. PubMed ID: 16637796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nevirapine-induced fulminant hepatitis.
    Maniar JK; Shah SR; Verma R; Kamath R; Gupte P; Maniar A
    J Assoc Physicians India; 2006 Dec; 54():957-8. PubMed ID: 17334017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal outcome of nevirapine-associated toxic epidermal necrolysis.
    Leng K; Lonsdorf A; Hartmann M
    Int J STD AIDS; 2008 Sep; 19(9):642-3. PubMed ID: 18725560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.